Found 31 matching trials
Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. PHASE2 The goal of this clinical trial is to learn whether letrozole, a hormone th...
Show More Location
Cancer Care Hospital and Research Centre Foundation
Learn More & Join Trial
Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer PHASE2 This trial will compare grade 2 or greater late skin toxicities of concomit...
Show More Location
CRLC Val d'Aurelle
Learn More & Join Trial
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer PHASE3 The present multi-center, open-label, single-arm study aims to evaluate the...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer PHASE3 The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Show More Location
Central Alabama Research
Learn More & Join Trial
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Aromatase ...
Show More Location
Centre Oscar Lambret
Learn More & Join Trial
Aromatase Inhibitor Host Factors Study NA The purpose of this study is to examine how key patient factors, including ...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer PHASE3 This multicenter, randomized, comparative study will evaluate the efficacy ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer PHASE3 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Learn More & Join Trial
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer PHASE3 Post-menopausal breast cancer patients will receive letrozole 2.5 mg daily ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Letrozole ...
Show More Location
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Learn More & Join Trial